Lantheus Holdings Inc

This proposal asks shareholders to cast a non-binding advisory vote to approve the compensation disclosed for the named executive officers (NEOs). Management is asking for ratification of its pay decisions described in the Compensation Discussion and Analysis, which emphasizes a pay-for-performance mix of base salary, annual cash incentives tied to corporate financial and strategic objectives, and long-term equity awards (including PSUs linked to relative TSR). The Board and the Talent and Compensation Committee present this advisory vote to solicit shareholder input; while the vote is not binding, the committee says it will strongly consider the outcome when setting future compensation. The proxy provides context including CD&A metrics (Net Revenue, Bonus EPS, strategic objectives), the design of the 2025 Executive Bonus Plan and long-term PSU structure, exceptions and discretion available to the committee, and prior strong shareholder support (~95% in 2025). Management highlights governance features that mitigate risk, such as clawback policy, stock ownership guidelines, no hedging/pledging, independent compensation consultant oversight, and minimum vesting periods. The request comes amid senior leadership transitions and significant M&A activity (two 2025 acquisitions and a divestiture) that management says impacted compensation decisions and required retention-focused awards. For an investor assessing the proposal, considerations include whether disclosed metrics and payout outcomes appropriately reward long-term value creation, whether discretion and special payments (e.g., acquisition-related awards, retention features) are justified, and whether governance protections sufficiently limit excessive risk-taking. Because the vote is advisory, a negative outcome would not nullify prior pay decisions but would likely trigger further engagement, potential plan adjustments, and closer scrutiny of the Talent and Compensation Committee’s policies and disclosures.

This advisory proposal asks shareholders to choose the interval—one, two, or three years—for future non-binding advisory votes on executive compensation. Management recommends an annual vote (ONE YEAR), arguing that yearly advisory votes provide frequent shareholder feedback and help the Board and Talent and Compensation Committee align pay programs with investor expectations. The vote is non-binding and determined by plurality; the Board will consider the shareholders’ preference but is not required to adopt it. The Company’s context—recent leadership transition, material M&A activity, and evolving executive pay design—supports management’s view that frequent engagement via annual votes is beneficial for timely course corrections and accountability. From an investor governance perspective, annual votes increase responsiveness and allow shareholders to react to rapid changes in compensation outcomes or corporate strategy, but they also increase administrative burden and can encourage short-term signaling. Some institutional investors prefer multi-year intervals to focus on longer-term pay outcomes (particularly for multi-year PSUs), so the choice can affect alignment between pay design measurement periods and shareholder input cadence. Importantly, a plurality result in favor of an interval other than one year would be considered the shareholder recommendation and the Board indicates it would review that outcome when setting future practices. For proxy voters, the decision hinges on whether they prioritize frequent shareholder feedback (favoring annual) or prefer aligning advisory input with multi-year performance cycles (favoring biennial or triennial).

This proposal asks shareholders to approve an amendment to the Company’s charter to eliminate the classified (staggered) board structure and transition to annual director elections over a three-year phase-in beginning in 2027. Management frames the change as responsive to prior shareholder input (a non-binding 2025 proposal requesting declassification) and as a measure to increase director accountability and shareholder influence over Board composition. The amendment also changes removal standards so that once declassified, directors may be removed with or without cause by a majority of votes, aligning removal rights with Delaware law and increasing shareholder leverage. The Board’s stated rationale balances the governance benefits of annual elections—greater accountability and alignment with shareholder preferences—against the continuity and takeover-defense benefits historically associated with classified boards. For investors and activists, declassification reduces the time horizon required to effect Board change and can influence governance contests, as annual elections lower barriers to board turnover. Conversely, management and certain long-term stakeholders may view declassification as increasing susceptibility to short-term pressures and potential opportunistic acquisitions. The proposal’s phased approach mitigates abrupt disruption by preserving current terms until the phase-in is complete, which preserves some continuity during the transition. From a risk/reward perspective, approving the amendment signals stronger shareholder rights and accountability but modestly raises the possibility of greater Board turnover and shorter-term focus; rejecting it retains structural continuity but may frustrate shareholders who previously expressed a clear preference for annual elections. Given the Board’s endorsement after deliberation and the Company’s prior engagement with shareholders, the recommendation to approve reflects responsiveness to investor governance expectations while attempting to preserve orderly change management.

This proposal requests shareholder approval to amend and restate the Company’s 2015 equity plan, principally to add 2,000,000 shares to the reserve and modernize plan mechanics for a larger, acquisition-driven company. Management argues the increase is needed to attract, retain and motivate talent after significant 2025 M&A activity (Evergreen and Life Molecular) and to support near-term hiring and retention; the Board also highlights governance guardrails including no evergreen provision, anti-repricing without shareholder approval, minimum vesting periods, a $2.0 million annual cash award cap per participant, and limits on non-employee director compensation (cash/equity combined caps). The proxy discloses the existing overhang and the post-amendment overhang (approximately 7.57% pre-proposal rising to ~10.65% after the additional shares), historical burn rates, and the Company’s expectation that the additional shares will support roughly one year of anticipated needs. The proposal removes legacy Section 162(m)-specific language that is no longer required post-TCJA and replaces numeric per-director share caps with value-based limits to provide flexibility while controlling dilution and pay levels. For shareholders evaluating the plan, key considerations are the dilution impact (overhang), the adequacy of the disclosed guardrails, the company’s historical share usage (burn rate), and the rationale tied to strategic growth and acquisitions. While management emphasizes competitive need and retention, investors will weigh whether the requested increase is sized appropriately and whether the plan’s anti-dilution, anti-repricing and minimum-vesting provisions sufficiently protect shareholders. If approved, the plan will enable continued equity-based compensation aligned with shareholder interests but will increase potential dilution in the short term; if not approved, the Company may need to substitute cash compensation or otherwise limit equity grants with potential retention consequences.